Target Price | $21.29 |
Price | $3.04 |
Potential |
600.19%
register free of charge
|
Number of Estimates | 7 |
7 Analysts have issued a price target aTyr Pharma, Inc. 2025 .
The average aTyr Pharma, Inc. target price is $21.29.
This is
600.19%
register free of charge
$35.00
1,051.32%
register free of charge
$9.00
196.05%
register free of charge
|
|
A rating was issued by 7 analysts: 7 Analysts recommend aTyr Pharma, Inc. to buy, 0 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the aTyr Pharma, Inc. stock has an average upside potential 2025 of
600.19%
register free of charge
|
Dec '23 |
2024 Estimates |
|
---|---|---|
Revenue Million $ | 0.35 | 0.25 |
96.63% | 27.74% | |
EBITDA Margin | -14,908.57% | -27,920.92% |
3,364.55% | 87.28% | |
Net Margin | -20,357.71% | -26,080.35% |
1,644.04% | 28.11% |
7 Analysts have issued a sales forecast aTyr Pharma, Inc. 2024 . The average aTyr Pharma, Inc. sales estimate is
This results in the following potential growth metrics:
1 Analyst has issued an EBITDA forecast aTyr Pharma, Inc. 2024 . The average aTyr Pharma, Inc. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
2 aTyr Pharma, Inc. Analysts have issued a net profit forecast 2024. The average aTyr Pharma, Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '23 |
2024 Estimates |
|
---|---|---|
Earnings Per Share $ | -0.94 | -0.87 |
41.25% | 7.45% | |
P/E | negative | |
EV/Sales | 654.96 |
2 Analysts have issued a aTyr Pharma, Inc. forecast for earnings per share. The average aTyr Pharma, Inc. <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2024, the aTyr Pharma, Inc. stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
aTyr Pharma, Inc....
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.